American Society of Interventional Pain Physicians

Dr. Lawrence Kirschenbaum Joins Physician Partners of America- West Palm Beach, FL

Retrieved on: 
Friday, March 31, 2023

WEST PALM BEACH, Fla., March 31, 2023 /PRNewswire-PRWeb/ -- Physician Partners of America (PPOA) is pleased to announce that interventional pain management specialist Lawrence Kirschenbaum, M.D., has joined the company's West Palm Beach, Florida pain management practice. He began seeing patients on March 6 at the office, located at 6910 S. Dixie Hwy, Suite 102, West Palm Beach, FL 33405.

Key Points: 
  • WEST PALM BEACH, Fla., March 31, 2023 /PRNewswire-PRWeb/ -- Physician Partners of America (PPOA) is pleased to announce that interventional pain management specialist Lawrence Kirschenbaum, M.D., has joined the company's West Palm Beach, Florida pain management practice.
  • He began seeing patients on March 6 at the office, located at 6910 S. Dixie Hwy, Suite 102, West Palm Beach, FL 33405.
  • Dr. Lawrence Kirschenbaum, is a notably experienced, board-certified, fellowship trained Interventional Pain Management Physician.
  • In addition to his practice of interventional pain management, Dr. Kirschenbaum remains an Associate Clinical Professor at the Yale University School of Medicine.

EVOKE Presentation Awarded Overall Winner at ASIPP Annual Meeting

Retrieved on: 
Wednesday, March 22, 2023

ARTARMON, Australia, March 22, 2023 /PRNewswire/ -- Saluda Medical Pty Limited ("Saluda Medical"), a global medical device company revolutionizing the field of neuromodulation, today announced that the EVOKE 36-month Study received the Outstanding Achievement in Research Award at the 25th annual meeting of the American Society of Interventional Pain Physicians (ASIPP) in National Harbor, MD. The plenary session presentation titled "ECAP-Based Spinal Cord Stimulation (SCS) for the Treatment of Chronic Pain: EVOKE Study 36-Month Outcomes" was presented by Dr. Sean Li, MD, Interventional Pain Physician and Clinical Researcher at Premier Pain Centers, Shrewsbury, NJ on behalf of the clinical study investigators.

Key Points: 
  • The plenary session presentation titled "ECAP-Based Spinal Cord Stimulation (SCS) for the Treatment of Chronic Pain: EVOKE Study 36-Month Outcomes" was presented by Dr. Sean Li, MD, Interventional Pain Physician and Clinical Researcher at Premier Pain Centers, Shrewsbury, NJ on behalf of the clinical study investigators.
  • The 36-month evidence from the EVOKE Study demonstrates the most enduring patient outcomes from a pivotal, randomized clinical study in the history of SCS.
  • The double-blind, RCT study included 134 randomized patients across 13 U.S. sites.
  • "The EVOKE Study is a major milestone in the evolution of spinal cord stimulation.

Dr. Ameer Ali Joins Physician Partners of America- Dallas, TX

Retrieved on: 
Friday, January 13, 2023

DALLAS, Jan. 13, 2023 /PRNewswire-PRWeb/ -- Physician Partners of America (PPOA) is pleased to announce that interventional pain management specialist Ameer Ali, M.D., has joined the company's North Dallas, Texas pain management practice. He began seeing patients on January 3 at the office, located at 7515 Greenville Ave, Suite 500, Dallas, TX 75231.

Key Points: 
  • DALLAS, Jan. 13, 2023 /PRNewswire-PRWeb/ -- Physician Partners of America (PPOA) is pleased to announce that interventional pain management specialist Ameer Ali, M.D., has joined the company's North Dallas, Texas pain management practice.
  • He began seeing patients on January 3 at the office, located at 7515 Greenville Ave, Suite 500, Dallas, TX 75231.
  • Dr. Ameer Ali is a warm-hearted, board-certified, specialized Spine Care fellowship trained Interventional Pain Management Physician.
  • Dr. Ali enthusiastically focuses on providing superlative treatment which is of the essence for the appropriate management of these painful conditions.

Padma Doniparthi, MD, DABA, DABPM, AAHPC, Joins Pain Specialists of America in Temple and Georgetown, TX

Retrieved on: 
Tuesday, September 6, 2022

Dr. Doniparthi is a best-in-class, triple board-certified interventional pain management physician with over 20 years of excellence.

Key Points: 
  • Dr. Doniparthi is a best-in-class, triple board-certified interventional pain management physician with over 20 years of excellence.
  • She has relocated to the Georgetown community from Brookfield, WI, where she practiced interventional pain medicine.
  • Dr. Padma Doniparthi is a diplomate of the American Board of Anesthesiology, Pain Management and Hospice and Palliative Care.
  • About Pain Specialists of America:
    Pain Specialists of America is an interventional pain management group with highly educated, double and triple-board-certified pain physicians.

Explore the Trippy World of Hallucinogens at PAINWeek 2022, on Friday, September 9, at The Cosmopolitan of Las Vegas

Retrieved on: 
Wednesday, August 24, 2022

MONTCLAIR, N.J., Aug. 24, 2022 /PRNewswire-PRWeb/ -- "Psychedelic medicine has been stigmatized and isolated from us for too long. Now is the time to revolutionize care for addiction, pain, and mental health using whatever tools we have, and psychedelic medicine is the most promising potential weapon in this battle," states Dr. Eugene Vortsman, who will be presenting at the PAINWeek National Conference, September 6-9, at The Cosmopolitan of Las Vegas, during the Psychedelics Track on Friday, September 9.

Key Points: 
  • Together, we will explore the trippy world of hallucinogens."
  • Eugene Vortsman, DO, FACEP, is Clinical Director of Addiction Medicine and Disease Management at Northwell Health, Long Island Jewish Medical Center in Queens, NY.
  • PAINWeek accreditation provided by Global Education Group:
    Global Education Group focuses on producing partnership-based CME for healthcare practitioners.
  • Global also holds accreditations to offer continuing education for nurse practitioners, pharmacists, dietitians, dentists, and psychologists.

PAINWeek 2022 Announces the Return of the International Pelvic Pain Society Track on September 8

Retrieved on: 
Thursday, August 18, 2022

MONTCLAIR, N.J., Aug. 18, 2022 /PRNewswire-PRWeb/ -- Worldwide, an estimated 26% of women have chronic pelvic pain (CPP). In the US, it's the reason for 40% of laparoscopies and 12% of hysterectomies annually, even though, in 80% of the patients, the origin of the pain is not gynecologic![1] Up to a third of women have repeated absences from work due to their pain.[2] One study found that 15% of US women of childbearing age say their pelvic pain has lasted at least 6 months.[3]

Key Points: 
  • [2] One study found that 15% of US women of childbearing age say their pelvic pain has lasted at least 6 months.
  • At the PAINWeek National Conference, September 6-9 at The Cosmopolitan of Las Vegas, the IPPSInternational Pelvic Pain SocietyTrack will provide the resources and knowledge to help attendees better understand pelvic pain.
  • The IPPS Track on Thursday, September 8, will include Dr. Georgine Lamvu presenting One Candle, Two Wicks: Managing Female Sexual Pain and Dysfunction.
  • Dr. Lamvu commented, "gender specific pain conditions, such as endometriosis and female sexual pain, contribute their own unique complexity to the evaluation and management of chronic pain.

The PAINWeek 2022 National Conference Presents the Advanced Practice Providers Track on Wednesday, September 7

Retrieved on: 
Thursday, August 4, 2022

MONTCLAIR, N.J., Aug. 4, 2022 /PRNewswire-PRWeb/ -- Advanced Practice Providers are making a difference in pain management. Recent articles have asked, "can advanced practice providers be the answer to the nursing crisis?" [1] and noted that NPs and PAs are/will be 67.3% of the practitioners added to the workforce between 2016 and 2030, outpacing physicians. [2]

Key Points: 
  • MONTCLAIR, N.J., Aug. 4, 2022 /PRNewswire-PRWeb/ -- Advanced Practice Providers are making a difference in pain management.
  • Recent articles have asked, "can advanced practice providers be the answer to the nursing crisis?"
  • PAINWeek is committed to providing advanced pain education to APPs at all stages of their careers, and 2022 promises to be the best conference yet.
  • Ms. Rowles is an associate professor of professional practice and director of the advanced pain management fellowship at Texas Christian University.

Nita N. Grover, MD, MPH is recognized by Continental Who's Who

Retrieved on: 
Tuesday, June 28, 2022

As a Pain Management Specialist, Dr. Grover first works to determine and understand the cause of pain in her patients.

Key Points: 
  • As a Pain Management Specialist, Dr. Grover first works to determine and understand the cause of pain in her patients.
  • She then tailors a treatment plan for patients to relieve, reduce or manage their pain.
  • The ultimate goal is to return the patients to their normal activities without surgery or heavy use of pain medicines.
  • She works with patients who have peripheral neuropathies, fibromyalgia, myofascial disease, chronic back and neck pain, and addiction or substance abuse issues.

Scilex, a Sorrento Company, Announces Pivotal Phase 3 SP-102 (SEMDEXA™) Data Presentation At The American Society Of Interventional Pain (ASIPP) 2022 Annual Meeting

Retrieved on: 
Friday, May 6, 2022

The pivotal Phase 3 SP-102 (SEMDEXATM) trial has a highly positive results evaluating SEMDEXATM in sciatica patients following an epidural injection was presented at the Innovation summit session of the 2022 American Society of Interventional Pain (ASIPP) Annual Scientific Meeting in Las Vegas, Nevada.

Key Points: 
  • The pivotal Phase 3 SP-102 (SEMDEXATM) trial has a highly positive results evaluating SEMDEXATM in sciatica patients following an epidural injection was presented at the Innovation summit session of the 2022 American Society of Interventional Pain (ASIPP) Annual Scientific Meeting in Las Vegas, Nevada.
  • This is the first time this trial study data has been presented at a major North American medical meeting.
  • The presentation at the Innovation Summit session, ASIPP on May 5, 2022, described the outcome of the C.L.E.A.R.
  • Program for SEMDEXA, its novel, non-opioid product for the treatment of lumbosacral radicular pain (sciatica), were announced in March 2022.

Clearway Pain Solutions Announces Newest Office Location in Bethesda, MD

Retrieved on: 
Monday, May 2, 2022

BETHESDA, Md., May 2, 2022 /PRNewswire/ -- It is with high anticipation that Clearway Pain Solutions announces their newest location in Bethesda, MD opening May 2022.

Key Points: 
  • BETHESDA, Md., May 2, 2022 /PRNewswire/ -- It is with high anticipation that Clearway Pain Solutions announces their newest location in Bethesda, MD opening May 2022.
  • The office will be located at 6410 Rockledge Dr #421 Bethesda, MD 20817 and will be staffed by Dr. Anna Irwin.
  • Clearway Pain Solutions is a leading interventional pain management practice focused on relieving pain, restoring function, and renewing the quality of life for their patients.
  • "I'm very excited to join the Bethesda community with the opening of Clearway's newest office location.